B
Barbara Amuron
Researcher at Uganda Virus Research Institute
Publications - 10
Citations - 604
Barbara Amuron is an academic researcher from Uganda Virus Research Institute. The author has contributed to research in topics: Psychosocial & Mortality rate. The author has an hindex of 8, co-authored 10 publications receiving 587 citations. Previous affiliations of Barbara Amuron include Medical Research Council.
Papers
More filters
Journal ArticleDOI
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial
Shabbar Jaffar,Barbara Amuron,Susan Foster,Josephine Birungi,Jonathan Levin,Geoffrey Namara,Christine Nabiryo,Nicaise Ndembi,Rosette Kyomuhangi,Alex Opio,Rebecca Bunnell,Jordan W. Tappero,Jonathan Mermin,Alex Coutinho,Heiner Grosskurth,Heiner Grosskurth +15 more
TL;DR: This home-based HIV-care strategy is as effective as is a clinic-based strategy, and therefore could enable improved and equitable access to HIV treatment, especially in areas with poor infrastructure and access to clinic care.
Journal ArticleDOI
Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda
Barbara Amuron,Barbara Amuron,Geoffrey Namara,Geoffrey Namara,Josephine Birungi,Christine Nabiryo,Jonathan Levin,Jonathan Levin,Heiner Grosskurth,Heiner Grosskurth,Alex Coutinho,Shabbar Jaffar +11 more
TL;DR: About a quarter of subjects eligible for ART did not complete screening and pre-treatment mortality was very high even though patients in this setting were well informed.
Journal ArticleDOI
Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study
Barbara Amuron,Jonathan Levin,Josephine Birunghi,Geoffrey Namara,Alex Coutinho,Heiner Grosskurth,Shabbar Jaffar +6 more
TL;DR: Practical and affordable interventions are needed to enable earlier initiation of ART and to reduce mortality risk among those who present late for treatment with advanced disease.
Journal ArticleDOI
The experience of “medicine companions” to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda
Susan Foster,Sarah Nakamanya,R. Kyomuhangi,J. Amurwon,Geoffrey Namara,Barbara Amuron,Christine Nabiryo,Josephine Birungi,B. Wolff,Shabbar Jaffar,Heiner Grosskurth +10 more
TL;DR: Qualitative interviews suggested MCs proved useful for reminding and other supportive tasks in the first three months but were generally less essential by six months and beyond, and generally welcome and useful in supporting early adherence.
Journal ArticleDOI
Use of WHO clinical stage for assessing patient eligibility to antiretroviral therapy in a routine health service setting in Jinja, Uganda
Shabbar Jaffar,Josephine Birungi,Heiner Grosskurth,Barbara Amuron,Geoffrey Namara,Christine Nabiryo,Alex Coutinho +6 more
TL;DR: There is an urgent need for greater CD4 count testing and evaluation of the utility of plasma viral load prior to initiation of ART to accompany the roll-out of ART.